EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g)
Recalled by GBC Food Services, LLC
Food recall
GBC Food Services, LLC
Class I — most serious
There is a reasonable chance that using this product could cause serious health problems or death.
GBC Food Services, LLC has recalled EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g), according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on January 14, 2026 and was initiated on November 22, 2025. It is classified as a Class I recall, which means there is a reasonable chance that using this product could cause serious health problems or death.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g), with approximately 11 units (7.73 lb) affected. The company behind the recall is GBC Food Services, LLC, based in Farmers Branch, TX. The FDA describes the product as: “EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g)”
Why was EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g) recalled?
According to the FDA, the stated reason for the recall is: “Potential presence of Listeria monocytogenes.” In plain terms, this recall relates to Listeria.
Listeria monocytogenes is a bacterium that can grow even at refrigerator temperatures, which makes it a particular concern in ready-to-eat foods. Health authorities warn that it can cause a serious infection called listeriosis, and that pregnant people, newborns, older adults, and those with weakened immune systems are especially vulnerable. This is why products potentially contaminated with Listeria are often recalled quickly.
What should you do?
If you think you may have bought EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g), compare it against the product description and identifying codes (UPC 85004224455 Best By 11/9/2025-11/22/2025) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact GBC Food Services, LLC or your local health authority.
About this recall
This recall was distributed in TX. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- January 14, 2026
- Recall started
- November 22, 2025
- Distributed in
- TX
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g) recalled?+
According to the FDA: Potential presence of Listeria monocytogenes.
How serious is this recall?+
Class I — most serious. There is a reasonable chance that using this product could cause serious health problems or death.
What should I do if I have EverRoast Chicken Caesar Wrap 85004224455 Net Wt: 11.25 oz (303g)?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: H-0382-2026. Information last synced from the FDA on July 5, 2026.